Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Single-Nucleotide Variations Defining Previously Unreported ADAMTS13 Haplotypes Are Associated With Differential Expression and Activity Of The VWF-Cleaving Protease In a Salvadoran Congenital Thrombotic Thrombocytopenic Purpura Family

Benjamin Kim, M.D., M.Phil., Zachary A. Hing, Andrew Wu, Tal Schiller, Evi B. Struble, Ph.D., David Liuwantara, Ph.D., Pamela H. Kempert, M.D., Eric J. Broxham, M.D., Nathan C. Edwards, Victor J. Marder, M.D., Vijaya L. Simhadri, Ph.D., Zuben E. Sauna, Ph.D., Tom E. Howard, M.D., Ph.D., Chava Kimchi-Sarfaty, Ph.D.

Blood (2013) 122 (21): 2319.

https://doi.org/10.1182/blood.V122.21.2319.2319

Published: 2013

Journal Articles

VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial,

Jerrold H Levy, MD, Nigel S. Key, MBChB, Andrew F Shorr, MD, MPH, Michael A Kurz, PhD, Victor J. Marder, M.D.

Blood (2011) 118 (21): 3293.

https://doi.org/10.1182/blood.V118.21.3293.3293

Published: 2011

Journal Articles

Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+ Cells Modified with a βAS3-Globin Lentiviral Vector

Fabrizia Urbinati, Ph.D, Zulema Romero Garcia, Ph.D, Sabine Geiger, Rafael Ruiz de Assin, Ph.D, Gabriela Kuftinec, Roger P. Hollis, PhD, Satiro N. De Oliveira, MD, Jennifer Wherley, Aaron Cooper, Tim M. Townes, PhD, Gay M. Crooks, MBBS, Elizabeth J Read, MD, Mark C. Walters, MD, Herbert J. Meiselman, ScD, Thomas D. Coates, MD, Victor J. Marder, M.D., Donald B. Kohn, MD

Blood (2011) 118 (21): 3119.

https://doi.org/10.1182/blood.V118.21.3119.3119

Published: 2011

Journal Articles

A Unique Recombinant Plasmin Molecule Lacking Kringles 2-5 Possesses Equivalent Hemostatic Safety as Full-Length Human Plasmin.

Victor J. Marder, MD, Valery Novokhatny, Steve Manyak, Theresa Gruber, Jennifer Hunt, John Bromirski, Abha Goyal, Philip Scuderi, Steve Petteway

Blood (2008) 112 (11): 2028.

https://doi.org/10.1182/blood.V112.11.2028.2028

Published: 2008

Journal Articles

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Theodore E. Warkentin, Richard J. Cook, Victor J. Marder, Jo-Ann I. Sheppard, Jane C. Moore, Bengt I. Eriksson, Andreas Greinacher, John G. Kelton

Blood (2005) 106 (12): 3791–3796.

https://doi.org/10.1182/blood-2005-05-1938

Published: 2005

Journal Articles

Analysis of Thrombi Retrieved from Cerebral Arteries of Patients with Acute Ischemic Stroke.

Victor J. Marder, MD, Dennis J. Chute, MD, Sidney Starkman, MD, Anna M. Abolian, Chelsea Kidwell, MD, David Liebeskind, MD, Bruce Obviagele, MD, Fernando Vinuela, MD, Gary Duckwiler, MD, Reza Jahan, MD, Paul M. Vespa, MD, Scott Selco, MD, Krishna Rajajee, MD, Jeffrey L. Saver, MD

Blood (2005) 106 (11): 263.

https://doi.org/10.1182/blood.V106.11.263.263

Published: 2005

Journal Articles

Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage.

Daphne Stewart, MD, Victor J. Marder, MD, Mansze Kong, MPH, Doris Quon, MD, PhD, Scott A. Cook, PhD, Gary Jesmok, PhD, Peter Radtke, PhD, George A. Baumbach, PhD

Blood (2004) 104 (11): 1864.

https://doi.org/10.1182/blood.V104.11.1864.1864

Published: 2004

Journal Articles

Fibrinogen faux pas

Victor J. Marder

Blood (2004) 103 (8): 2867–2868.

https://doi.org/10.1182/blood-2004-02-0573

Published: 2004

Journal Articles

Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage

Daphne Stewart, Mansze Kong, Valery Novokhatny, Gary Jesmok, Victor J. Marder

Blood (2003) 101 (8): 3002–3007.

https://doi.org/10.1182/blood-2002-08-2546

Published: 2003

Journal Articles

Degradation of Bovine Factor VIII by Plasmin and Trypsin

Edward P. Kirby, Ph.D., Neil Martin, Victor J. Marder, M.D.

Blood (1974) 43 (5): 629–640.

https://doi.org/10.1182/blood.V43.5.629.629

Published: 1974

Journal Articles

Isoimmune Neonatal Thrombocytopenic Purpura : Clinical and Therapeutic Considerations

HOWARD A. PEARSON, M.D., N. RAPHAEL SHULMAN, M.D., VICTOR J. MARDER, M.D., THOMAS E. CONE, JR., M.D.

Blood (1964) 23 (2): 154–177.

https://doi.org/10.1182/blood.V23.2.154.154

Published: 1964

NARROW

Single-Nucleotide Variations Defining Previously Unreported ADAMTS13 Haplotypes Are Associated With Differential Expression and Activity Of The VWF-Cleaving Protease In a Salvadoran Congenital Thrombotic Thrombocytopenic Purpura Family

VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial,

Preclinical Studies for Sickle Cell Disease Gene Therapy Using Bone Marrow CD34+ Cells Modified with a βAS3-Globin Lentiviral Vector

A Unique Recombinant Plasmin Molecule Lacking Kringles 2-5 Possesses Equivalent Hemostatic Safety as Full-Length Human Plasmin.

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Analysis of Thrombi Retrieved from Cerebral Arteries of Patients with Acute Ischemic Stroke.

Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage.

Fibrinogen faux pas

Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage

Degradation of Bovine Factor VIII by Plasmin and Trypsin

Isoimmune Neonatal Thrombocytopenic Purpura : Clinical and Therapeutic Considerations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only